éå»1ã¶æéã«Rigel Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã5åã«åºã¥ãããŒã¿ã
仿ãRIGLã¯1ä»¶ã®ãè²·ããã2ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããRIGLã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯63.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.933ã«ç¶ããRIGLã®FY2026Q3ã®EPSã¯0.837ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.93 ã§ããããRigel Pharmaceuticals IncRIGL ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.47 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.84 ãšäºæ³ãããŸãã